Top Ten most popular articles on Pharmafile.com this week
pharmafile | January 31, 2020 | News story | Medical Communications | Janseen, Ketamine, NHS, NICE, Nasal sprays, Nasl, Top 10 of the week, top 10
This week nasal sprays based on illegal recreational drugs feature prominently, as the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for the introduction of local anaesthesia of the mucous membranes for diagnostic procedures and surgeries. This is contrary to NICE in the UK which rejected Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, for use in England and Wales for treatment-resistant depression.
10. Janssen’s ulcerative colitis medicine not recommended by NICE for use in adults
NICE has published draft guidance which does not recommend Stelara (ustekinumab) for treating moderately to severely active ulcerative colitis in adults, due to concerns about cost-effectiveness.
9. NICE rejects Janssen’s esketamine nasal spray Spravato for treatment-resistant depression
Janssen’s Spravato (esketamine) nasal spray, derived from the party drug ketamine, has been turned down by NICE for NHS use in England and Wales for treatment-resistant depression, it has emerged.
8. BioIntelliSense’ BioSticker sensor approved by the FDA
BioIntelliSense has secured 510 (k) clearance from the FDA for its biosticker sensor for remote care.
7. NICE refuses Novo Nordisk’s obesity therapy Saxenda for NHS use
NICE, the drug watchdog for England and Wales, has revealed that it has chosen not to recommend Novo Nordisk’s Saxenda (liraglutide) for the weight management in obese or overweight patients.
6. Johnson & Johnson working on coronavirus vaccine
Johnson & Johnson has become the latest pharmaceutical company to begin work on a vaccine for the Chinese coronavirus.
5. FDA approves MS drug for human trials
A drug that can make it easier to diagnose Multiple Sclerosis (MS) has been approved for its first human trials by the FDA.
4. Healthy cells in lungs can repair the damage from smoking
Human lungs have the ‘magical’ ability to repair the cancerous mutations caused by smoking cigarettes, but only if people quit smoking.
3. FDA approves Lannett’s cocaine-based nasal spray
It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the introduction of local anaesthesia of the mucous membranes for diagnostic procedures and surgeries.”
2. FDA approves Teva’s Ajovy autoinjector for treatment of migraine
Israeli pharma firm Teva has revealed that the FDA has chosen to award approval to its autoinjector device for the delivery of its Ajovy (fremanezumab-vfrm) solution, used to treat patients with migraine.
1. FDA approves Lannett’s cocaine-based nasal spray
It has been announced that the FDA has moved to approve Lannett Company’s Numbrino (cocaine hydrochloride) nasal solution for “the introduction of local anaesthesia of the mucous membranes for diagnostic procedures and surgeries”.
Related Content
“That gap between innovation and delivery was what stood out to me most”
Pharmafile chats with Camunda’s Natosha McNeal about the vital role of delivery, onboarding AI and …
Fortysomethings’ non-attendance at NHS Health Checks raises concerns, says study
People in their forties account for almost three-quarters of those who do not attend NHS …
NICE recommends daratumumab quadruplet for newly diagnosed multiple myeloma
NICE has published final draft guidance recommending daratumumab with bortezomib, lenalidomide and dexamethasone (D-VRd) for …
